Cannell & Co. Xencor Inc Transaction History

Cannell & Co.

$3.01 Billion
Q4 2023

A detailed history of Cannell & Co. transactions in Xencor Inc stock. As of the latest transaction made, Cannell & Co. holds 12,600 shares of XNCR stock, worth $253,386. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,600

Holding current value

$253,386

% of portfolio

0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$16.53 - $21.42 $208,278 - $269,892	12,600 New	12,600 $267,000
Q2 2022 Aug 08, 2022	SELL	$19.74 - $29.01 $12,929 - $19,001	-655 Reduced 7.82%	7,725 $211,000
Q1 2021 May 07, 2021	SELL	$40.81 - $53.88 $2,856 - $3,771	-70 Reduced 0.83%	8,380 $361,000
Q4 2020 Feb 11, 2021	SELL	$36.63 - $47.63 $80,586 - $104,786	-2,200 Reduced 20.66%	8,450 $369,000
Q1 2020 May 05, 2020	BUY	$20.69 - $37.79 $48,621 - $88,806	2,350 Added 28.31%	10,650 $318,000
Q4 2019 Feb 10, 2020	BUY	$32.75 - $41.43 $68,775 - $87,003	2,100 Added 33.87%	8,300 $285,000
Q3 2019 Nov 12, 2019	SELL	$33.73 - $46.27 $6.81 Million - $9.34 Million	-201,910 Reduced 97.02%	6,200 $209,000
Q2 2019 Aug 12, 2019	SELL	$29.6 - $40.93 $529,100 - $731,623	-17,875 Reduced 7.91%	208,110 $8.52 Million
Q1 2019 May 14, 2019	BUY	$27.85 - $38.09 $108,754 - $148,741	3,905 Added 1.76%	225,985 $7.02 Million
Q4 2018 Feb 11, 2019	BUY	$32.39 - $42.05 $114,336 - $148,436	3,530 Added 1.62%	222,080 $8.03 Million
Q3 2018 Nov 05, 2018	SELL	$35.69 - $47.65 $92,794 - $123,890	-2,600 Reduced 1.18%	218,550 $8.52 Million
Q2 2018 Aug 06, 2018	SELL	$28.41 - $42.41 $215,916 - $322,316	-7,600 Reduced 3.32%	221,150 $8.19 Million
Q1 2018 May 09, 2018	BUY	$21.18 - $33.78 $97,428 - $155,388	4,600 Added 2.05%	228,750 $6.86 Million
Q4 2017 Feb 13, 2018	BUY	$19.29 - $24.83 $463,924 - $597,161	24,050 Added 12.02%	224,150 $4.91 Million
Q3 2017 Nov 08, 2017	BUY	$19.61 - $23.35 $3.92 Million - $4.67 Million	200,100	200,100 $4.59 Million

Others Institutions Holding XNCR

# of Institutions

204

Shares Held

63.1M

Call Options Held

3.9K

Put Options Held

Black Rock Inc. New York, NY

11.1M
Shares

$223 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

9.12M
Shares

$183 Million
0.13% of portfolio
Vanguard Group Inc Valley Forge, PA

7M
Shares

$141 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.33M
Shares

$107 Million
3.57% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.96M
Shares

$79.7 Million
0.01% of portfolio

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.2B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.

Account